# Zhongke Haichuang

> Zhongke Haichuang is a VC fund in Weifang backing Artificial Intelligence and Robotics. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Weifang, China
- Total investments: 7
- Last investment: Jan 2024
- Lead investor: 43%
- Last updated: Aug 2026

Zhongke Haichuang is a VC fund in Weifang focused on Artificial Intelligence and Robotics. Zhongke Haichuang offer investment management and investment consulting service.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 3 | 43% |
| Robotics | 2 | 29% |
| Health Care | 2 | 29% |
| Medical | 1 | 14% |
| Software | 1 | 14% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 29% |
| Series C | 2 | 29% |
| Series A | 1 | 14% |
| Funding Round | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Manteia | Manteia is committed to deep learning, data technology, and traditional algorithm research in the field of tumor radiotherapy. Manteia is headquartered in Xiamen, China, it has a wholly-owned subsidiary in the United States. It is a foreign-introduced "Double Hundred Talents" enterprise by Xiamen Municipal Government and a strategicinvestment enterprise in the field of radiotherapy by Fosun Group and Danlu Capital.The company has R&D teams in China and the United States, with about 50 algorithms and engineers, of which 40% are doctors and 30% are masters. The core R&D personnel have published more than 170 SCI-indexed documents in the field of radiotherapy. It has 26 software copyrights, 2 international patents and 6 domestic patents. | $15.4M | Series B | Jan 18, 2024 |  |
| Huichuang Medical | Huichuang Medical is a neuro-imaging technique and tools developer. | $13.7M | Series B | Oct 31, 2023 |  |
| Fitow | Fitow develops automotive management and quality insurance platform that provides sales management, personnel management, production management, and quality control management services through AI technology and Big Data analysis for the automotive industry. | $13.7M | Series B | Sep 04, 2023 |  |
| Milestone | Milestone offers cell and gene therapy-related services. | $14.2M | Series A | Aug 22, 2023 |  |
| Bairui Data | Bairui Data is a data intelligence fundamental software firm that focuses on "Data+AI." Build a data intelligence platform, create software and hardware integrated data processing products, and empower the digital transformation and upgrading of the government and national industries based on completely independent research anddevelopment of a new generation of full-memory distributed database product systems and artificial intelligence product system. |  | Venture - Series Unknown | Dec 23, 2022 |  |
| Cobot | Cobot offers advanced-learning-algorithms-driven solutions for facilitating the use of industrial robots.Cobot is the first company in the world to propose an intelligent operating system for industrial robots. With the world-class top R&D team, it has deeply cultivated core technologies such as artificial intelligence 3D vision and forcecontrol, and implanted the machine learning algorithm model into the “robot brain” COBOTSYS. Ensuring that industrial robots are safe, stable, and easy to use, tightly connecting end users, robot manufacturers and system integrators to quickly meet customer needs.In the next five years, Cooper's original "robot brain" COBOTSYS will become the connecting center of millions of robots, creating a robotic environment that everyone can use, freeing people from a boring, dangerous and repetitive environment. |  | Series C | Jul 25, 2022 |  |
| Cobot | Wuhan Cobot Technology is a Chinese intelligent robot manipulation system provider, offering solutions for companies in the industry of electronics, food, apparel, grocery, pharmaceuticals to build industrial robots. Its products include unsorted grasping system, force controlled polishing system and drag teaching system. |  | Series C | Jul 23, 2022 |  |

7 of 7 investments shown.

## Co-investors
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 2 deals together
- [Guoxin Fund](https://shizune.co/investors/profile/guoxin-fund) — VC Fund, 2 deals together
- [AlphaX Partners](https://shizune.co/investors/profile/alphax-partners-fund) — VC Fund, 1 deal together
- [Hefei Industry Investment Group](https://shizune.co/investors/profile/hefei-industry-investment-group) — VC Fund, 1 deal together
- [Hillhouse Ventures](https://shizune.co/investors/profile/hillhouse-ventures) — VC Fund, 1 deal together
- [Shanghai SIIC Fund Management](https://shizune.co/investors/profile/shanghai-siic-fund-management) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Zhongke Haichuang invest in?

Zhongke Haichuang invests primarily in Artificial Intelligence, Robotics and Health Care startups, most often at Series B and Series C stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhongke Haichuang last invest?

The most recent investment recorded for Zhongke Haichuang closed in Jan 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co